You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-C-MYC (MYC) Antibodies

Full name:
anti-V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) Antibodies (MYC)
On are 696 V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) Antibodies from 34 different suppliers available. Additionally we are shipping C-MYC Kits (37) and C-MYC Proteins (30) and many more products for this protein. A total of 792 C-MYC products are currently listed.
AU016757, bHLHe39, C-MYC, CMyc, LOC100136746, mMyc, MRTL, MYC, Myc2, MYCC, Niard, Nird, RNCMYC, zc-myc

All available anti-C-MYC Antibodies

Go to our pre-filtered search.

Top referenced anti-C-MYC Antibodies

  1. Human Polyclonal C-MYC Primary Antibody for EIA, WB - ABIN358293 : Qi, Gregory, Li, Brousal, West, Hann: p19ARF directly and differentially controls the functions of c-Myc independently of p53. in Nature 2004 (PubMed)
    Show all 5 references for ABIN358293

  2. Human Monoclonal C-MYC Primary Antibody for IF, IHC (p) - ABIN1105578 : Liao, Thakur, Wu, Biliran, Sarkar: Perspectives on c-Myc, Cyclin D1, and their interaction in cancer formation, progression, and response to chemotherapy. in Critical reviews in oncogenesis 2008 (PubMed)
    Show all 4 references for ABIN1105578

  3. Human Polyclonal C-MYC Primary Antibody for EIA, WB - ABIN4620436 : Lima, Bousquet, Gomez-Brouchet, de Paiva, Amstalden, Soares, Dastugue, Vassallo, Brousset: Primary diffuse large B-cell lymphoma of bone displays preferential rearrangements of the c-MYC or BCL2 gene. in American journal of clinical pathology 2008 (PubMed)
    Show all 3 references for ABIN4620436

  4. Human Polyclonal C-MYC Primary Antibody for EIA, WB - ABIN4620435 : Ida, Ogata, Okumura, Taguchi: Changes in the gene expression of C-myc and CD38 in HL-60 cells during differentiation induced by nicotinic acid-related compounds. in Bioscience, biotechnology, and biochemistry 2008 (PubMed)
    Show all 3 references for ABIN4620435

  5. Human Polyclonal C-MYC Primary Antibody for EIA, IHC (p) - ABIN4620434 : Iijima, Teraoka, Date, Tsukada: DNA-activated protein kinase in Raji Burkitt's lymphoma cells. Phosphorylation of c-Myc oncoprotein. in European journal of biochemistry / FEBS 1992 (PubMed)
    Show all 3 references for ABIN4620434

  6. Human Monoclonal C-MYC Primary Antibody for EIA, FACS - ABIN119684 : Spandidos, Pintzas, Kakkanas, Yiagnisis, Mahera, Patra, Agnantis: Elevated expression of the myc gene in human benign and malignant breast lesions compared to normal tissue. in Anticancer research 1988 (PubMed)
    Show all 2 references for ABIN119684

  7. Human Monoclonal C-MYC Primary Antibody for FACS, IHC (fro) - ABIN119682 : Evan, Lewis, Ramsay, Bishop: Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. in Molecular and cellular biology 1986 (PubMed)
    Show all 2 references for ABIN119682

  8. Human Polyclonal C-MYC Primary Antibody for WB - ABIN2668789 : Kohn, Yang, Du, Nagano, Van Schyndle, Herrmann, Heldman, Chen, Stuelten, Flanders, Wakefield: Biological responses to TGF-β in the mammary epithelium show a complex dependency on Smad3 gene dosage with important implications for tumor progression. in Molecular cancer research : MCR 2012 (PubMed)

  9. Mammalian Monoclonal C-MYC Primary Antibody for IF, IP - ABIN1105582 : Watanabe, Honma, Furusawa, Sakurai, Sato: Preparation of enzymatically active human Myc-tagged-NCre recombinase exhibiting immunoreactivity with anti-Myc antibody. in Molecular reproduction and development 2006 (PubMed)

More Antibodies against C-MYC Interaction Partners

Mouse (Murine) V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) interaction partners

  1. Data show that the reprogramming factors OCT4 (show POU5F1 Antibodies), SOX2 (show SOX2 Antibodies), KLF4 (show KLF4 Antibodies), and MYC (OSKM) drive cells along two distinct and parallel pathways, one pluripotent and one endodermal.

  2. Expression of c-myc and ethanol-uptake synergistically accelerate the progression of Aalcoholic liver disease most likely due to loss of p53 (show TP53 Antibodies)-dependent protection.

  3. our study provides valuable information on the molecular interactions between OSKM(Oct4 (show POU5F1 Antibodies), Sox2 (show SOX2 Antibodies), Klf4 (show KLF4 Antibodies), and Myc) and cofactors and molecular mechanisms for the functional importance of Set1a (show SETD1A Antibodies) in ESCs (show NR2E3 Antibodies) and early development.

  4. ASCIZ (show ATMIN Antibodies) and its target DYNLL1 (show DYNLL1 Antibodies) are essential for the development and expansion of MYC-driven B cell lymphoma.

  5. Srebp-1 (show SREBF1 Antibodies) interacts with c-Myc, facilitates its binding to downstream pluripotent targets.

  6. MCL-1 (show MCL1 Antibodies) loss in early B-lymphoid progenitors delayed MYC-driven lymphomagenesis.

  7. Somatic cell transfer of c-Myc and Bcl-2 (show BCL2 Antibodies) induces large-cell anaplastic medulloblastomas in mice.

  8. constitutive STAT5 (show STAT5A Antibodies) binding to c-Myc super-enhancer might contribute to BRD2 (show BRD2 Antibodies) maintenance and thus allow sustained expression of c-Myc in Ba/F3 cells transformed by STAT5 (show STAT5A Antibodies)-1*6.

  9. These results identify c-Myc as a key controller of memory CD8 (show CD8A Antibodies)(+) T cells from costimulatory signals.

  10. mice. In vitro assays revealed enhanced survival capacity of Myc-driven cells lacking FoxO3 (show FOXO3 Antibodies), but no change in cell cycling was detected

Zebrafish V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) interaction partners

  1. Apoptosis was also observed with myca expression; introduction of homozygous tp53 (show TP53 Antibodies)(-/-) mutation into the myca transgenic fish reduced apoptosis and accelerated tumor progression.

  2. MYC down-regulation induces mitochondrial apoptosis in T lymphoblasts.

Human V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) interaction partners

  1. Results showed an upregulation of CCAT1 detected in adult acute myeloid leukemia (show BCL11A Antibodies) (AML (show RUNX1 Antibodies)) patients. It repressed monocytic differentiation and promoted cell growth by sequestering tumor suppressive miR (show MLXIP Antibodies)-155 which expression significantly decrease in AML (show RUNX1 Antibodies) patients but increases c-myc expression.

  2. This discovery suggested that miR (show MLXIP Antibodies)-451 is a tumor suppressor modulating bladder cancer cell migration and invasion by directly targeting c-Myc

  3. Data show that phosphoinositide-3-kinase, catalytic, delta polypeptide (PIK3CD) can promote proliferation and prevent apoptosis in diffuse large B cell lymphoma (DLBCL) cells in vitro through upregulation of c-myc protein.

  4. our findings indicate that the expression levels of P-GP (show ABCB4 Antibodies), MYC, caspase-8 (show CASP8 Antibodies), and AKT3 (show AKT3 Antibodies) are candidate biomarkers of cell sensitivity to PLKis.

  5. our data indicated that there is a regulatory feedback loop between miR-17-5p and c-Myc, in which miR-17-5p could suppress some of the distinguishing features, invasion, and metastasis, of oncogenic c-Myc in HCC (show FAM126A Antibodies) cells, and meanwhile, miR-17-5p is upregulated by c-Myc role as a transcription factor, although further studies are still needed

  6. FUBP1 (show FUBP1 Antibodies) may potentially stimulate c-Myc expression in ESCC and its expression may promote esophageal squamous cell carcinoma progression.

  7. NFATC1 (show NFATC1 Antibodies) promoteds growth of ovarian cancer cells up-regulating c-myc through activation of ERK1/2 (show MAPK1/3 Antibodies)/p38/MAPK (show MAPK14 Antibodies) signal pathway.

  8. CD30 (show TNFRSF8 Antibodies) expression was not associated with prognosis in our cohort of de novoDLBCL, including in patients who received aggressive chemotherapy. CD30 (show TNFRSF8 Antibodies) expression and MYC rearrangement were mutually exclusive in de novoDLBCL.

  9. the present study clearly demonstrates that silencing ABCB1 (show ABCB1 Antibodies), but not c-myc, led to a considerable enhancement of chemosensitivity in HepG2/Dox cells, indicating the reversal of ABC transporter (show ABCG2 Antibodies)-mediated MDR.

  10. Case Report: diffuse large B-cell lymphoma exhibiting MYC-IGH rearrangement and gain of BCL2 (show BCL2 Antibodies).

Rabbit V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) interaction partners

  1. report the isolation of complete coding regions of rabbit SOX2, KLF4, C-MYC and NANOG, which encode transcription factors that play crucial regulatory roles during early mammalian embryonic development

Cow (Bovine) V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) interaction partners

  1. Ouabain-induced proliferation might be attributed, at least in part, to decrease of intracellular free calcium and increase of c-myc mRNA expression, and that may be directly or indirectly involved in regulation of blood pressure.

C-MYC (MYC) Antigen Profile

Antigen Summary

The protein encoded by this gene is a multifunctional, nuclear phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation. It functions as a transcription factor that regulates transcription of specific target genes. Mutations, overexpression, rearrangement and translocation of this gene have been associated with a variety of hematopoietic tumors, leukemias and lymphomas, including Burkitt lymphoma. There is evidence to show that alternative translation initiations from an upstream, in-frame non-AUG (CUG) and a downstream AUG start site result in the production of two isoforms with distinct N-termini. The synthesis of non-AUG initiated protein is suppressed in Burkitt's lymphomas, suggesting its importance in the normal function of this gene.

Alternative names and synonyms associated with C-MYC (MYC)

  • v-myc myelocytomatosis viral oncogene homolog (LOC100136746) antibody
  • myelocytomatosis oncogene (Myc) antibody
  • myelocytomatosis oncogene a (myca) antibody
  • v-myc avian myelocytomatosis viral oncogene homolog (MYC) antibody
  • v-myc myelocytomatosis viral oncogene homolog (MYC) antibody
  • v-myc myelocytomatosis viral oncogene homolog (avian) (MYC) antibody
  • AU016757 antibody
  • bHLHe39 antibody
  • C-MYC antibody
  • CMyc antibody
  • LOC100136746 antibody
  • mMyc antibody
  • MRTL antibody
  • MYC antibody
  • Myc2 antibody
  • MYCC antibody
  • Niard antibody
  • Nird antibody
  • RNCMYC antibody
  • zc-myc antibody

Protein level used designations for MYC

v-myc myelocytomatosis viral oncogene homolog , Avian myelocytomatosis viral (v-myc) oncogene homolog , myc proto-oncogene protein , myelocytomatosis viral oncogene homolog , proto-oncogene c-Myc , transcription factor p64 , v-myc avian myelocytomatosis viral oncogene homolog , c-myc proto-oncogene , C-Myc1 , c-Myc-A , cellular myelocytomatosis oncogene , cmyca , transcriptional regulator Myc-A , avian myelocytomatosis viral oncogene homolog , class E basic helix-loop-helix protein 39 , myc-related translation/localization regulatory factor , avian myelocytomatosis viral (v-myc) oncogene homolog , c-Myc , Proto-oncogene c-Myc , Transcription factor p64 , Myc proto-oncogene protein

100136746 Oncorhynchus mykiss
24577 Rattus norvegicus
17869 Mus musculus
30686 Danio rerio
4609 Homo sapiens
420332 Gallus gallus
100327265 Oryctolagus cuniculus
403924 Canis lupus familiaris
448810 Sus scrofa
511077 Bos taurus
100379628 Felis catus
443447 Ovis aries
694626 Macaca mulatta
464393 Pan troglodytes
100407754 Callithrix jacchus
100972175 Pan paniscus
Selected quality suppliers for anti-C-MYC (MYC) Antibodies
Did you look for something else?